Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop

Author： van Etten Richard A.  

Publisher： Informa Healthcare

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.54, Iss.6, 2013-06, pp. : 1151-1158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current status of therapy for chronic myeloid leukemia: a review of drug development

By Padmanabhan Swami   Ravella Saritha   Curiel Tyler   Giles Francis  

Future Oncology, Vol. 4, Iss. 3, 2008-06 ,pp. : 359-377

Future Medicine

Access to resources Recommend Favorite

Increased IFN- synthesis by T cells from patients on imatinib therapy for chronic myeloid leukemia

By Jorg M Aswald  

Cytokines, Cellular & Molecular Therapy, Vol. 7, Iss. 4, 2002-12 ,pp. : 143-149

Informa Healthcare

Access to resources Recommend Favorite

Imatinib and chronic myeloid leukemia: close to the bone

By Terpos Evangelos  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1581-1582

Informa Healthcare

Access to resources Recommend Favorite

Chronic Myeloid Leukemia: The Value of Tyrosine Kinase Inhibition

By Tariq I. Mughal   John M. Goldman  

American Journal of Cancer, Vol. 2, Iss. 5, 2003-01 ,pp. : 305-311

Adis International

Access to resources Recommend Favorite

Ever-advancing chronic myeloid leukemia treatment

By Kimura Shinya   Ando Toshihiko   Kojima Kensuke  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 3-9

Springer Publishing Company

Access to resources Recommend Favorite